Boston Scientific Corporation (BSX) to Buy BridgePoint Medical for Undisclosed Amount
9/19/2012 9:06:39 AM
More...
|
BridgePoint Medical Announces Licensing Agreement for its Peripheral Vascular Products
1/18/2012 10:07:46 AM
More...
|
BridgePoint Medical Announces US IDE Approval and First Patient Enrollment of Peripheral Chronic Total Occlusion Study
8/3/2011 12:52:34 PM
More...
|
BridgePoint Medical Announced 510(k) Clearance for an Expanded Indication to Treat Coronary Chronic Total Occlusions
5/16/2011 9:55:13 AM
More...
|
BridgePoint Medical Names Industry Veteran as Chief Executive Officer
3/21/2011 7:53:33 AM
More...
|
BridgePoint Medical Closes $9.1 Million Series C Financing
3/11/2011 6:49:27 AM
More...
|
BridgePoint Medical Raises $9M For Device to Unblock Blood Vessels
12/22/2010 7:28:40 AM
More...
|
Minnesota Device Maker BridgePoint Medical Raises $1 Million
11/18/2010 8:18:29 AM
More...
|
BridgePoint Medical Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss(R) and Stingray(R) CTO Recanalization System
10/5/2010 7:15:50 AM
More...
|
BridgePoint Medical Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
11/23/2009 9:45:25 AM
More...
|
|